L&G Pharma Breakthrough UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.49 %TER
£17.97M Fund size
40Number of positions
— TD
33.02 %Top 10 share
USDCurrency
4SRI

Top 10 Holdings

Here you can see the 10 largest positions of the L&G Pharma Breakthrough UCITS ETF.

Name Industry CountryWeight
1Xeris Biopharma Holdings Inc
Healthcare United States of America
Healthcare United States of America 5.22 %
2Genmab A/S
Healthcare Denmark
Healthcare Denmark 3.99 %
3Xencor Inc
Healthcare United States of America
Healthcare United States of America 3.39 %
4United Therapeutics Corp
Healthcare United States of America
Healthcare United States of America 3.10 %
5Biogen Inc.
Healthcare United States of America
Healthcare United States of America 2.98 %
6BeOne Medicines Ltd ADR
Healthcare United States of America
Healthcare United States of America 2.95 %
7AstraZeneca
Healthcare United Kingdom
Healthcare United Kingdom 2.90 %
8Eisai Co. Ltd.
Healthcare Japan
Healthcare Japan 2.87 %
9Royalty Pharma PLC Class A
Healthcare United States of America
Healthcare United States of America 2.81 %
10Basilea Pharmaceutica Ltd Registered Shares
Healthcare Switzerland
Healthcare Switzerland 2.81 %

Asset classes

Here you can see the asset classes of the L&G Pharma Breakthrough UCITS ETF.

Currencies

Here you can see the currency breakdown of L&G Pharma Breakthrough UCITS ETF.

US Dollar
68.70 %
Japanese Yen
10.83 %
Euro
4.29 %
Danish Krone
3.99 %
British Pound
2.90 %
Swiss Franc
2.81 %
Swedish Krona
2.57 %
South Korean Won
1.96 %
Hong Kong Dollar
1.84 %

Regions

Here you can see the regional breakdown.

Other
68.70 %
Other
16.56 %
Other
14.63 %

Country allocation

This ETF invests in these countries L&G Pharma Breakthrough UCITS ETF.

United States of America
68.70 %
Japan
10.83 %
Denmark
3.99 %
United Kingdom
2.90 %
Switzerland
2.81 %
Sweden
2.57 %
France
2.45 %
South Korea
1.96 %
China
1.84 %
Spain
1.84 %

Sectors

Here you can see the sector breakdown of L&G Pharma Breakthrough UCITS ETF.

Healthcare
97.93 %
Basic Materials
1.96 %

Currencies

Here you can see the currency breakdown of L&G Pharma Breakthrough UCITS ETF.

US Dollar
68.70 %
Japanese Yen
10.83 %
Euro
4.29 %
Danish Krone
3.99 %
British Pound
2.90 %
Swiss Franc
2.81 %
Swedish Krona
2.57 %
South Korean Won
1.96 %
Hong Kong Dollar
1.84 %

Data as of: 18 Nov 2026

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.